In the face of the coronavirus crisis, all radiologists can do for some of their pathologist peers is stand, salute and express solidarity.

“This is one of the first times that artificial intelligence has been used to better define the different parts of a newborn's brain on an MRI," Canadian researchers explained March 26 in Frontiers in Neuroscience.

The fully digital modality can also offer insights into various neurodegenerative diseases, German researchers wrote. 

"This study presents a significant advancement in addressing a major unmet clinical need: the accurate arrhythmia localization in patients with a variety of heart rhythm disorders," one Johns Hopkins Medicine expert noted.

"It is our hope that in [the] future doctors might be able to use a device like ours to precisely identify diseases as they develop at the cellular level, in real-time, and in high resolution," researchers wrote.

The material increases magentic resonance sensitivity so that providers can visualize abnormal tissue changes indicative of metastasis.

Sandia National Laboratories will use the award to create a wearable magnetoencephalography brain imaging prototype.

It's been tested in mouse models, but was recently approved for investigational use in small breast-cancer clinical trials.

“This study shows a disheartening rate of inadequate exams among mpMRI studies of the prostate,” experts wrote in Academic Radiology.

These new recovery milestones will allow clinicians to pinpoint whether or not a patient is responding to therapy or making the necessary strides toward rehabilitation.

The discovery came after researchers combed through hundreds of brain scans and found that nearly 40% of patients did not have the reduced gray matter volumes typically seen in those with the disorder.

This information can help clinicians adjust the quantitative standards used to asses how a patient's heart is functioning.